Cornerstone Investment Partners, LLC Alkermes Plc. Transaction History

Cornerstone Investment Partners, LLC

  • $1.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$21.47 - $32.08 $161,561 - $241,402
-7,525 Closed
0 $0
Q3 2021

Oct 25, 2021
SELL
$23.37 - $32.13 $42,066 - $57,834
-1,800 Reduced 19.3%
7,525 $232,000
Q2 2021

Jul 29, 2021
BUY
$18.78 - $25.15 $175,123 - $234,523
9,325 New
9,325 $229,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email